| Literature DB >> 12093492 |
Yuji Mano1, Toshiko Aoki, Yumiko Kikuchi, Yoshiaki Soeishi, Takashi Usui, Hidetaka Kamimura.
Abstract
A specific method for the determination of YM466, a novel Factor Xa inhibitor, in rat and dog plasma was developed and validated. YM466 was extracted from plasma by solid-phase extraction and analyzed by UV-HPLC at an absorbance wavelength of 240 nm. The intra-day precision and accuracy ranged from 0.8 to 2.4% and 0.1 to 5.0% in rats, and from 1.6 to 2.4% and 0.0 to 4.1% in dogs, respectively. The lower limit of quantification was 10 ng/ml when 1 ml of plasma was used. No endogenous interference was observed in the plasma of rats and dogs.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12093492 DOI: 10.1016/s0731-7085(02)00103-6
Source DB: PubMed Journal: J Pharm Biomed Anal ISSN: 0731-7085 Impact factor: 3.935